Today's Daily Dose brings you news about the release of FDA's briefing document related to Aradigm's investigational drug Linhaliq; AmpliPhi's stock offering; Halozyme's rosy outlook on royalty revenue growth and Tandem Diabetes' preliminary Q4 results.
from RTT - Biotech http://ift.tt/2Fmzzyg
via IFTTT
No comments:
Post a Comment